Posterior Urethral Valve



Fig. 70.1
a Micturating cystourethrogram showing dilated bladder with no vesicoureteric reflux. Note the dilated posterior urethra indicative of posterior urethral valve. b micturating cystourethrogram showing a dilated posterior urethra indicative of posterior urethral valve





A321246_1_En_70_Fig2_HTML.gif


Fig. 70.2
a and b Micturating cystourethrogram showing dilated posterior urethra indicative of posterior urethral valve. Note the marked right sided and left sided vesicoureteric reflux





  • Visualization of the valve leaflets


  • A thickened trabeculated urinary bladder


  • A dilated or elongated posterior urethra


  • A hypertrophied bladder neck


  • The presence of diverticula, vesicoureteral reflux, and reflux into the ejaculatory ducts


  • Very thickened hypertrophied urinary bladder wall which may lead to secondary ureterovesical junction obstruction


  • Renal scintigraphy





    • Tc-dimercaptosuccinic acid (DMSA) and mercaptoacetyltriglycine (MAG-3) renal scintigraphy provide information about relative renal function and areas of scarring or dysplasia.


    • MAG-3 renal scan with furosemide (Lasix) also provides information about renal drainage and possible obstruction.


  • Urodynamic evaluation:





    • Provides information about bladder storage and emptying.


    • The term “valve bladder” is used to describe patients with PUV and a fibrotic noncompliant bladder.


    • These patients are at risk of developing hydroureteronephrosis, progressive renal deterioration, recurrent infections, and urinary incontinence.


    • Patients with PUV require periodic urodynamic evaluation throughout childhood because bladder compliance may further deteriorate over time.


  • Cystoscopy: serves both diagnostic and therapeutic functions.





    • Diagnostic cystoscopy:





      • ◦ Confirm the diagnosis


    • Therapeutic cystoscopy:





      • ◦ Transurethral incision of the PUV.


      • ◦ Multiple techniques have been described for ablating the valves.


      • ◦ Currently, valves are disrupted under direct vision by cystoscopy using an endoscopic loop, Bugbee electro cauterization, or laser fulguration.


      • ◦ In extremely small infants (< 2000 g), a 2F Fogarty catheter may be passed either under fluoroscopic or under direct vision for valve disruption.


      • ◦ In some patients, the urethra may be too small and a temporary vesicostomy is performed.





      Secondary effects of PUV:






      • Vesicoureteral reflux (Fig. 70.3)



        A321246_1_En_70_Fig3_HTML.jpg


        Fig. 70.3
        Micturating cystourethrogram showing vesicoureteric reflux (left), which is severe in the second picture (right)





        • Vesicoureteral reflux is commonly associated with PUV and is present in as many as one third of patients .


        • When associated with PUV, reflux is generally secondary to elevated intravesical pressures.


        • The treatment of vesicoureteral reflux in patients with PUV involves treatment of intravesical pressures using :



          1.

          Anticholinergics

           

          2.

          Timed voiding

           

          3.

          Double voiding

           

          4.

          Intermittent catheterization

           

          5.

          Bladder augmentation

           


      • UTIs





        • Recurrent UTIs are common in patients with PUV. These are secondary to :



          1.

          Elevated intravesical pressures

           

          2.

          Increased post void residual urine volumes, leading to stasis of urine.

           

          3.

          Dilated upper urinary tracts, with or without vesicoureteral reflux.

           


        • UTI management is directed at:



          1.

          Lowering bladder pressures (anticholinergic medication)

           

          2.

          Lowering post void residual urine volume (via clean intermittent catheterization)

           

          3.

          Administering prophylactic antibiotics

           





      • Urinary incontinence





        • The same factors that lead to vesicoureteral reflux and UTI also lead to urinary incontinence .


        • Correct management of bladder function depends on adequate bladder evaluation with urodynamic studies.


        • These include:



          1.

          Lowering bladder pressure.

           

          2.

          Improving bladder compliance.

           

          3.

          Minimizing post void residual urine volume.

           

          4.

          In some, bladder augmentation may be needed .

           



      Pathophysiology




    • Mar 8, 2017 | Posted by in PEDIATRICS | Comments Off on Posterior Urethral Valve

      Full access? Get Clinical Tree

      Get Clinical Tree app for offline access